LTRN (Lantern Pharma Inc.) Stock Financials & Earnings | Market Cap Arena

LTRN (Lantern Pharma Inc.) Stock Financials & Earnings | Market Cap Arena

LTRNLantern Pharma Inc.

Mkt Cap$31M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$19M

EPS (TTM)-$1.75

Free Cash Flow (TTM)-$17M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q4 2025 · Mar 26

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$4M
Q1 23	$0	$0	-$4M
Q2 23	$0	$0	-$5M
Q3 23	$0	$0	-$4M
Q4 23	$0	-$44K	-$5M
Q1 24	$0	$0	-$6M
Q2 24	$0	$0	-$5M
Q3 24	$0	$0	-$5M
Q4 24	$0	-$51K	-$6M
Q1 25	$0	$0	-$5M
Q2 25	$0	$0	-$5M
Q3 25	$0	-$4K	-$4M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$3M	-$3M
Q1 23	-$4M	-$4M
Q2 23	-$4M	-$4M
Q3 23	-$4M	-$4M
Q4 23	-$3M	-$3M
Q1 24	-$3M	-$3M
Q2 24	-$5M	-$5M
Q3 24	-$6M	-$6M
Q4 24	-$4M	-$4M
Q1 25	-$4M	-$4M
Q2 25	-$4M	-$4M
Q3 25	-$5M	-$5M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$7K
Q1 23	$9K
Q2 23	$1
Q3 23	$5K
Q4 23	$5K
Q1 24	$2K
Q2 24	$4K
Q3 24	$3K
Q4 24	$3K
Q1 25	$1K
Q2 25	$3
Q3 25	$560

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	+9.0%
Q1 23	—	+5.4%
Q2 23	—	+18.1%
Q3 23	—	+64.3%
Q4 23	—	+27.5%
Q1 24	—	+33.7%
Q2 24	—	+4.2%
Q3 24	—	+47.0%
Q4 24	—	+20.9%
Q1 25	—	-16.7%
Q2 25	—	-14.0%
Q3 25	—	-16.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$330K	—
Q1 23	$334K	—
Q2 23	$0	—
Q3 23	$191K	—
Q4 23	$151K	—
Q1 24	$134K	—
Q2 24	$134K	—
Q3 24	$179K	—
Q4 24	$285K	—
Q1 25	$148K	—
Q2 25	$161K	—
Q3 25	$144K	—

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q4 22	$2M	$2M	—	—
Q1 23	$3M	$2M	—	—
Q2 23	$4M	$2M	$72K	—
Q3 23	$2M	$1M	$49K	—
Q4 23	$4M	—	—	$1M
Q1 24	$4M	$1M	$50K	—
Q2 24	$4M	$2M	—	—
Q3 24	$4M	$1M	$53K	—
Q4 24	$4M	—	—	$2M
Q1 25	$3M	$1M	$58K	—
Q2 25	$3M	$2M	$58K	—
Q3 25	$2M	—	—	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$37M	$18M	$55M
Q1 23	$33M	$19M	$52M
Q2 23	$28M	$20M	$48M
Q3 23	$26M	$19M	$45M
Q4 23	$22M	$19M	$41M
Q1 24	$18M	$20M	$38M
Q2 24	$13M	$20M	$33M
Q3 24	$8M	$20M	$28M
Q4 24	$8M	$17M	$24M
Q1 25	$6M	$13M	$20M
Q2 25	$6M	$10M	$16M
Q3 25	$8M	$4M	$12M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	11M	+0.1%
Q1 23	11M	+0.0%
Q2 23	11M	+0.0%
Q3 23	11M	+0.0%
Q4 23	11M	-0.5%
Q1 24	11M	-0.5%
Q2 24	11M	+0.1%
Q3 24	11M	+0.0%
Q4 24	11M	+0.2%
Q1 25	11M	+0.0%
Q2 25	11M	+0.0%
Q3 25	11M	+0.5%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$0	15
FY 21	$0	14
FY 22	$0	100
FY 23	$0	21
FY 24	$0	100